In addition, a study from the Queen Mary University in London [48] suggested that persons with a prior allergic disease, particularly asthma have a lower risk to develop severe COVID-19, perhaps because the expression of ACE2 is lower in people with allergic asthma and allergic sensitization [39]. This evidence concerns the gene ACE2 and COVID-19.